Clinical Trial Update: Efficacy and Safety of TJ0113 Capsule in Patients With Parkinson's Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of TJ0113 Capsule in Parkinson's disease has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• TJ0113 Capsule (TJ0113)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Parkinson Disease | Phase 2 | Status: COMPLETED | Results posted: 2026-01-16